Ablation of AKT1 or AKT2 in murine breast cancer models and of AKT1 or AKT2 in human breast cell lines was associated with suppression of tumor progression and cell-cycle progression, increased apoptosis, and an overall reduced metastatic potential of target cells. The gene discussed is AKT2; the disease is breast cancer.